Chinmoy Nandi
Research Subjects
Chinmoy Nandi has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adittya Sabhayasachi Khan
Department of Biochemistry and Molecular Biology, University of Dhaka, Dhaka, 1000, Bangladesh
1 shared publication - Mahmud Hossain
Department of Biochemistry and Molecular Biology, Laboratory of Neuroscience and Neurogenetics, University of Dhaka, Dhaka, Bangladesh
1 shared publication - Md Al Amin
Department of Biochemistry and Molecular Biology, Jagannath University, Dhaka, 1100, Bangladesh
1 shared publication - Md. Rafiqul Islam1 shared publication
- Mir Mohammad Ehsanul Haque
Department of Biochemistry and Molecular Biology, Jagannath University, Dhaka, 1100, Bangladesh
1 shared publication - Pritom Das Ruddro1 shared publication
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Computational Identification of Bioactive Phytocompounds from Bangladeshi Medicinal Plants as Potential Inhibitors of Dengue Virus Serotype 2 NS2B–NS3 Protease
The clinical manifestations of dengue virus (DENV) infections are classified as Neglected Tropical Diseases (NTDs) by the World Health Organization (WHO). About 20,000 people die each year in tropical and subtropical regions, and more than 2.5 billion individuals are at risk. Researchers have an eye on natural compounds for DENV treatment due to the lack of effective medications and a widely accepted vaccination. The DENV2 NS3 protein, with protease activity, is key for host cell viral replication. NS2B is linked with NS3 protein as a cofactor. Hence, NS2B-NS3 is a potential druggable target, because inhibiting this enzyme complex greatly reduces DENV-associated infection. Currently, there are some antiviral drugs with poor efficacy, which encourages the search for possible inhibitors of the DENV2 NS2B-NS3 protease using computational methods. This study aims to identify potential inhibitors against the DENV2 NS2B-NS3 protease using Molecular docking, ADMET analysis, MD simulation, MM/PBSA, QSAR and DFT calculations. A total of 5,841 phytochemicals, derived from 40 traditional medicinal plants, were screened against the NS2B-NS3 protease, with the compounds retrieved from the IMPPAT (Indian Medicinal Plants, Phytochemistry and Therapeutics) database. Two potential phytocompounds (CID 5204 and CID 99474) exhibited binding affinities of -9.7 and -9.4 kcal/mol, respectively, higher than the control compound. Furthermore, MD simulation of 200 ns validated the stability of these compounds when complexed with the target protein. This research identified promising new phytochemicals targeting DENV2 NS2B-NS3 protease, which may serve as potential leads for the development of effective antiviral drugs for dengue treatment.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessComputational Identification of Bioactive Phytocompounds from Bangladeshi Medicinal Plants as Potential Inhibitors of Dengue Virus Serotype 2 NS2B–NS3 Protease
The clinical manifestations of dengue virus (DENV) infections are classified as Neglected Tropical Diseases (NTDs) by the World Health Organization (WHO). About 20,000 people die each year in tropical and subtropical regions, and more than 2.5 billion individuals are at risk. Researchers have an eye on natural compounds for DENV treatment due to the lack of effective medications and a widely accepted vaccination. The DENV2 NS3 protein, with protease activity, is key for host cell viral replication. NS2B is linked with NS3 protein as a cofactor. Hence, NS2B-NS3 is a potential druggable target, because inhibiting this enzyme complex greatly reduces DENV-associated infection. Currently, there are some antiviral drugs with poor efficacy, which encourages the search for possible inhibitors of the DENV2 NS2B-NS3 protease using computational methods. This study aims to identify potential inhibitors against the DENV2 NS2B-NS3 protease using Molecular docking, ADMET analysis, MD simulation, MM/PBSA, QSAR and DFT calculations. A total of 5,841 phytochemicals, derived from 40 traditional medicinal plants, were screened against the NS2B-NS3 protease, with the compounds retrieved from the IMPPAT (Indian Medicinal Plants, Phytochemistry and Therapeutics) database. Two potential phytocompounds (CID 5204 and CID 99474) exhibited binding affinities of -9.7 and -9.4 kcal/mol, respectively, higher than the control compound. Furthermore, MD simulation of 200 ns validated the stability of these compounds when complexed with the target protein. This research identified promising new phytochemicals targeting DENV2 NS2B-NS3 protease, which may serve as potential leads for the development of effective antiviral drugs for dengue treatment.